Scientific and technological prospection on transdermal formulations and complementary therapies for the treatment of primary dysmenorrhea
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2019.1562547
Abstract: ABSTRACT Introduction: Primary dysmenorrhea (PD) is another term for idiopathic menstrual cramps. Treatments include the use of oral non-steroidal anti-inflammatory drugs (NSAIDs). These drugs have several side effects. The objective of this study was to… read more here.
Keywords: complementary therapies; primary dysmenorrhea; technological prospection; therapies treatment ... See more keywords
Technological prospection: patents mapping involving compounds for the treatment of L-DOPA-induced dyskinesias
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2019.1690453
Abstract: ABSTRACT Introduction: Parkinson’s disease (PD), is a disorder debilitant characterized by the reduction of nigrostriatal dopaminergic neurons within the midbrain, specifically in the substantia nigra pars compacta, which results for the dopamine (DA) depletion in… read more here.
Keywords: induced dyskinesias; treatment; technological prospection; dopa induced ... See more keywords